Larvol Delta - Abdera-Therapeutics-Announces-FDA-Orphan-Drug-Designation-for-ABD147-for-the-Treatment-of-Neuroendocrine-Carcinoma

ABD-147 - Abdera Therap

https://www.businesswire.com/news/home/20240904002278/en/Abdera-Therapeutics-Announces-FDA-Orphan-Drug-Designation-for-ABD-147-for-the-Treatment-of-Neuroendocrine-Carcinoma

Sep 5, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next